期刊文献+

2-丙硫基-4,6-二氯-5-氨基嘧啶的合成 被引量:1

Preparation of 2-Propylthio-4,6-dichloro-5-aminopyrimidine
原文传递
导出
摘要 丙二酸二乙酯、硫脲环合生成硫代巴比妥酸钠,在碘化四丁铵催化下经溴丙烷烷基化,再与30%~40%硝酸经管式硝化反应制得2-丙硫基-4,6-二羟基-5-硝基嘧啶,最后经氯代、还原合成了抗凝血药替卡格雷的重要中间体2-丙硫基-4,6-二氯-5-氨基嘧啶,总收率约67%。 2-Propylthio-4,6-dichloro-5-aminopyrimidine, the key intermediate of ticagrelor, was synthesized from diethyl malonate and thiourea by cyclization to give sodium 2-thiobarbiturate, followed by alkylation with bromopropane in presence of TBAI and nitration using 30% - 40% nitric acid in tubular reactor to afford 2-propylthio- 4,6-dihydroxy-5-nitropyrimidine, which was subjected to chlorination and reduction with an overall yield of 67 %.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2013年第6期557-559,共3页 Chinese Journal of Pharmaceuticals
关键词 替卡格雷 2-丙硫基-4 6-二氯-5-氨基嘧啶 中间体 合成 ticagrelor 2-propylthio-4,6-dichloro-5-aminopyrimidine intermediate synthesis
  • 相关文献

参考文献10

  • 1陈莉莉,岑均达.替卡格雷合成路线图解[J].中国医药工业杂志,2011,42(2):146-150. 被引量:13
  • 2杨臻峥,晋展.抗凝血药替卡格雷[J].药学进展,2008,32(9):425-427. 被引量:5
  • 3Nair V, Trivedi N, Khile AS, et al. Novel process for preparing triazolo [4,5-d] pyrimidine derivatives and intermediates thereof: WO, 2012085665 [P]. 2003-06-28.
  • 4Khile AS, Patel J, Trivedi N, et al. Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2- (propylthio) pyrimidine : WO, 2011101740 [P]. 2011-08-25.
  • 5Crepaldi P, Cacciari B. 6-Amino-2-mercapto-3H-pyrimidin- 4-one derivatives as new candidates for the antagonism at the P2Y12 receptors [J]. Bioorg Med Chem, 2009, 17 (13): 4612-4621.
  • 6Larsson U, Magnusson M, Musil T, et al. Novel triazolo pyrimidine compounds: US, 2003148888 [P]. 2003-08-07.
  • 7Rao T, Zhang CZ. Cyclopropyl modulators of P2Y12 receptor: WO, 2011017108 [P]. 2011-02-10.
  • 8Latli B, Jones PJ. Synthesis of [^14C] [^13C4] -, and [ ^13C4,^15N2] -5-amino-4-iodopyrimidine [ J]. J Label CompdRadio Pharm, 2008, 51: 54-58.
  • 9Baindur N, Chadha N, Player M. Solution-phase synthesis of a library of 3,5,7-trisubstituted-3H- [ 1,2,3 ] triazolo [4,5-at] pyrimidines [J]. J Comb Chem, 2003, 5: 653-659.
  • 10Czeskis BA. Synthesis of triple [14C] -labeledmoxonidine [J]. J Label Compd Radio Pharm, 2004, 47: 699-704.

二级参考文献20

  • 1Owen RT,Serradell N,Bolos J.AZD6140[J].Drugs Future,2007,32 (10):845-853.
  • 2Hardern D,Ingall A,Springthorpe B,et al.Triazolo (4,5-d)pyrimidine compounds:US,6525060[P].2003-02-25.
  • 3Larsson U,Magnusson M,Musil T,et al.Novel triazolo pyrimidine compounds:US,2003148888[P].2003-08-07.
  • 4Just G,Cutrone L.2,3-Oxazabicyclo[2.2.1] heptane[J].Can J Chem,1976,54:867-870.
  • 5Jung M,Offenbacher G,Retey J.Total synthesis of neplanocin A[J].Helv Chim Acta,1983,66(7):1915-1921.
  • 6Welch JT,Lin J.Fluoroolefin containing dipeptide isosteres as inhibitors of dipeptidyl peptidase IV (CD26)[J].Tetrahedron,1996,52 (1):291 -304.
  • 7Ahlford K,Zaitsev AB,Ekstrom J,et al.A simple and efficient catalyst system for the asymmetric transfer hydrogenation of ketones[J].Synlett,2007,16:2541-2544.
  • 8Shireman BT,Miller MJ.Rapid syntheses of either enantiomer of important carbocyclic nucleoside precursors[J].Tetrahedron Lett,2000,41 (49):9537-9540.
  • 9Ranganathan S,George KS.2-Aza-3-oxabicyclo[2.2.1] heptene hydrochloride:an exceptionally versatile synthon for carbocyclic sugars and nucleosides[J].Tetrahedron,1997,53 (9):3347-3362.
  • 10Springthorpe B,Bailey A,Barton P,et al.From ATP to AZD6140:the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis[J].Bioorg Med Chem Lett,2007,17 (21):6013-6018.

共引文献15

同被引文献6

  • 1Wallentin L, C Becker R, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syn- d:mes[ J ]. N Engl J M:a,2009,361(11) ::O45 - 1057.
  • 2Khile A S, Patel J, Trivedi N, et al. Improved proces- ses for preparing ticagrelor intermediate,4,6-dichloro-5- nitro-2-(propyhhio) pyrimidine [ P ]. WO 201 110 174 OA1,2011.
  • 3Bohlin M H, Hellstroem H, W Johansson P, et al. Process for preparing {[ IS-( 1-alpha, 2-alpha, 3-beta ( 1 S*, 2R* ) 5-beta ] } -3- { 7- [ 2- ( 3,4 -difluorophenyl )- cyclopropylamino ] -5-( propyhhio ) -3H-1,2, 3-triazolo [4,5-d ] pyrimidin-3-yl } -5-( 2-hydroxyethoxy ) cyelo- pentane-1,2-diol and to its intermediates [ P]. US 20 120 101 274A1,2012.
  • 4Larsson U, Magnusson M, Musil T, et al. Novel tri- azolo pyrimidine compounds [ P]. US 20 110 218 330A1,2011.
  • 5陈莉莉,岑均达.替卡格雷合成路线图解[J].中国医药工业杂志,2011,42(2):146-150. 被引量:13
  • 6霍韶伟,郭晔堃,钟静芬,时惠麟.新型抗血小板药替卡格雷[J].上海医药,2012,33(3):21-23. 被引量:7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部